Costa Max, Davidson Todd L, Chen Haobin, Ke Qingdong, Zhang Ping, Yan Yan, Huang Chuanshu, Kluz Thomas
Department of Environmental Medicine, NYU School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA.
Mutat Res. 2005 Dec 30;592(1-2):79-88. doi: 10.1016/j.mrfmmm.2005.06.008. Epub 2005 Jul 11.
Both water soluble and insoluble nickel compounds have been implicated in the etiology of human lung and nasal cancers. Water insoluble nickel compounds have been shown to enter cells by phagocytosis and are contained in cytoplasmic vacuoles, which are acidified thus accelerating the dissolution of soluble nickel from the particles. Using Newport Green, a dye that fluoresces when ionic nickel is bound, we have shown that following exposure (48-72 h) of human lung (A549) cells to NiS particles, most of the nickel is contained in the nucleus, while cells exposed to soluble NiCl2 exhibit most of the ions localized in the cytoplasm. This effect is consistent with previously published reports showing that short-term exposure of cells to crystalline nickel particles (1-3 days) is able to epigenetically silence target genes placed near heterochromatin, while similar short-term exposure to soluble nickel compounds are not able to induce silencing of genes placed near heterochromatin. However, a 3 week exposure of cells to soluble NiCl2 is also able to induce gene silencing. A similar effect was found in yeast cells where nickel was able to silence the URA-3 gene placed near (1.3 kb) a telomere silencing element, but not when the gene was placed farther away from the silencing element (2.0 kb). In addition to epigenetic effects, nickel compounds activate hypoxia signaling pathways. The mechanism of this effect involves the ability of either soluble or insoluble nickel compounds to block iron uptake leading to cellular iron depletion, directly affect iron containing enzymes, or both. This results in the inhibition of a variety of iron-dependent enzymes, such as aconitase and the HIF proline hydroxylases (PHD1-3). The inhibition of the HIF proline hydroxylases stabilizes the HIF protein and activates hypoxic signaling. Additional studies have shown that nickel and hypoxia decrease histone acetylation and increase the methylation of H3 lysine 9. These events are involved in gene silencing and hypoxia can also cause these effects in human cells. It is hypothesised that the state of hypoxia either by low oxygen tension or as a result of agents that signal hypoxia under normal oxygen tension (iron chelation, nickel and cobalt) results in low levels of acetyl CoA, which is a substrate for histone and other protein acetylation. This effect may in part be responsible for the gene silencing following nickel exposure and during hypoxia.
水溶性和水不溶性镍化合物都与人类肺癌和鼻癌的病因有关。水不溶性镍化合物已被证明可通过吞噬作用进入细胞,并存在于细胞质液泡中,这些液泡会被酸化,从而加速可溶性镍从颗粒中的溶解。使用纽波特绿(Newport Green),一种在与离子镍结合时会发出荧光的染料,我们已经表明,在人肺(A549)细胞暴露于硫化镍颗粒(48 - 72小时)后,大部分镍存在于细胞核中,而暴露于可溶性氯化镍的细胞则表现出大部分离子位于细胞质中。这种效应与先前发表的报告一致,这些报告表明细胞短期暴露于结晶镍颗粒(1 - 3天)能够在表观遗传上使位于异染色质附近的靶基因沉默,而类似的短期暴露于可溶性镍化合物则不能诱导位于异染色质附近的基因沉默。然而,细胞暴露于可溶性氯化镍3周也能够诱导基因沉默。在酵母细胞中也发现了类似的效应,镍能够使位于端粒沉默元件附近(1.3 kb)的URA - 3基因沉默,但当该基因距离沉默元件更远(2.0 kb)时则不能。除了表观遗传效应外,镍化合物还会激活缺氧信号通路。这种效应的机制涉及可溶性或不溶性镍化合物阻断铁摄取导致细胞内铁缺乏的能力,直接影响含铁酶,或两者兼而有之。这会导致多种铁依赖性酶的抑制,如乌头酸酶和缺氧诱导因子脯氨酸羟化酶(PHD1 - 3)。缺氧诱导因子脯氨酸羟化酶的抑制会使缺氧诱导因子蛋白稳定并激活缺氧信号。进一步的研究表明,镍和缺氧会降低组蛋白乙酰化并增加H3赖氨酸9的甲基化。这些事件与基因沉默有关,缺氧在人类细胞中也会导致这些效应。据推测,无论是低氧张力导致的缺氧状态,还是在正常氧张力下由信号缺氧的物质(铁螯合剂、镍和钴)引起的缺氧状态,都会导致乙酰辅酶A水平降低,而乙酰辅酶A是组蛋白和其他蛋白质乙酰化的底物。这种效应可能部分是镍暴露后和缺氧期间基因沉默的原因。